In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol

J Nucl Med. 1990 Dec;31(12):2015-21.

Abstract

A new dopamine D2 receptor radiotracer, N-11C-methyl-benperidol (11C-NMB), was prepared and its in vivo biologic behavior in mice and a baboon was studied. Carbon-11-NMB was determined to bind to specific sites characterized as dopamine D2 receptors. The binding was saturable, reversible, and stereospecific. Kinetic studies in the dopamine D2 receptor-rich striatum showed that 11C-NMB was retained five times longer than in receptor-devoid regions, resulting in a high maximum striatal-to-cerebellar ratio of 11:1 at 60 min after injection. From frontal cortex and cortex, on the other hand, the tracer washed out as rapidly as it did from cerebellum, resulting in tissue-to-cerebellar ratios close to one in these regions at any time after injection. Blocking studies confirmed the specificity and selectivity of the 11C-NMB binding to the dopamine D2 receptor. A PET study with 11C-NMB of the baboon brain revealed highly selective labeling of dopamine D2 receptor sites which was blocked by preinjection of raclopride.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benperidol / analogs & derivatives*
  • Benperidol / chemical synthesis
  • Benperidol / metabolism
  • Benperidol / pharmacokinetics
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Carbon Radioisotopes
  • Male
  • Mice
  • Papio
  • Protein Binding
  • Receptors, Dopamine / metabolism*
  • Receptors, Dopamine D2
  • Tomography, Emission-Computed

Substances

  • Carbon Radioisotopes
  • Receptors, Dopamine
  • Receptors, Dopamine D2
  • N-methylbenperidol
  • Benperidol